News from oxurion nv A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

19 Dec, 2018, 06:30 GMT Oxurion NV to Present at 2019 Biotech Showcase[TM] Conference and Participate in CEO Power Breakfast Roundtable During the 37th Annual J.P. Morgan Healthcare Conference

Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases...


05 Nov, 2018, 16:40 GMT Oxurion and Beta Therapeutics to Develop New Heparanase Inhibitors for Treatment of dry AMD

Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases...


29 Oct, 2018, 06:30 GMT Oxurion NV Announces the Appointment of Adrienne Graves to Its Board of Directors

Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics NV), a biopharmaceutical company developing innovative treatments to preserve...


24 Oct, 2018, 06:30 BST Oxurion NV to Present at the Upcoming Ophthalmology Innovation Summit and Provide a Clinical Update at the American Academy of Ophthalmology 2018 Annual Meeting

Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve...


22 Oct, 2018, 07:30 BST Oxurion NV Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Project

Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve...